Compounds from diverse natural origin against triple‐negative breast cancer: A comprehensive review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Compounds from diverse natural origin against triple‐negative breast cancer: A comprehensive review

Published:2022-11-15 Issue:1 Volume:101 Page:218-243
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Thilagavathi Ramasamy¹,Priyankha Sridhar²,Kannan Manivel³,Prakash Muthuramalingam²,Selvam Chelliah⁴^ORCID

Affiliation:

1. Department of Biotechnology, Faculty of Engineering Karpagam Academy of Higher Education Coimbatore India

2. Department of Chemistry, Faculty of Engineering and Technology SRM Institute of Science and Technology Chengalpattu India

3. Faculty of Pharmacy Karpagam Academy of Higher Education Coimbatore India

4. Department of Pharmaceutical Sciences College of Pharmacy and Health Sciences, Texas Southern University Houston Texas USA

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.14172

Reference137 articles.

1. Corymbulosins I–W, Cytotoxic Clerodane Diterpenes from the Bark of Laetia corymbulosa

2. Comparative anticancer activities of Ficus carica and Ficus salicifolia latex in MDA-MB-231 cells

3. Carnosol, a Natural Polyphenol, Inhibits Migration, Metastasis, and Tumor Growth of Breast Cancer via a ROS-Dependent Proteasome Degradation of STAT3

4.

Effects of Annona muricata Extract on Triple-Negative Breast Cancer Cells Mediated Through EGFR Signaling

5. The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action;International Journal of Molecular Sciences;2024-06-06

2. The therapeutic potential of natural metabolites in targeting endocrine-independent HER-2-negative breast cancer;Frontiers in Pharmacology;2024-03-04

3. The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production;Biomolecules;2024-01-05

4. Recent biological applications of heterocyclic hybrids containing s-triazine scaffold;RSC Advances;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3